GlassScriptPhysician profile
Jason Gronert
NPI 1184070823
$2,465.14
in general payments reported to CMS, 2019-2025
25 companies · $82.02 in 2025
The $82.02 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $85.93 · 2021: $420 · 2022: $924 · 2023: $433 · 2024: $520 · 2025: $82.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $860 · Education: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $859.96 |
| Education | $174.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $600.72 | 2022 | |
| Astellas Pharma US INC | $518.93 | 2021-2025 | Veozah |
| Aspira Women'S Health INC | $153.33 | 2021 | |
| Abbvie INC. | $137.67 | 2020-2023 | |
| Coopersurgical, INC. | $105.58 | 2021-2024 | Wallach Cryosurgical Equipment, Paragard T 380a |
| Organon LLC | $102.38 | 2021-2023 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $100.13 | 2020-2023 | |
| Therapeuticsmd, INC. | $83.88 | 2020-2022 | |
| Hologic Sales and Service, LLC | $83.23 | 2023 | Acessa Provu System, Aptima |
| Exeltis, USA INC. | $73.43 | 2020-2024 | Slynd |
| Mayne Pharma Commercial LLC | $58.69 | 2022-2024 | |
| Roche Diagnostics Corporation | $54.64 | 2021 | |
| Medtronic, INC. | $52.95 | 2021-2023 | Interstim |
| Sumitomo Pharma America, INC. | $50.32 | 2023 | Myfembree, Gemtesa |
| Dexcom, INC. | $45.24 | 2024 | Dexcom G6 Transmitter |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $40.86 | 2021-2022 | |
| Boston Scientific Corporation | $37.66 | 2024-2025 | Solyx Sis System |
| Pfizer INC. | $32.90 | 2022-2023 | |
| Applied Medical Resources Corporation | $22.51 | 2020 | |
| Genzyme Corporation | $22.07 | 2023 | |
| Ethicon US, LLC | $21.90 | 2023 | Enseal, Dermabond Prineo |
| Sage Therapeutics, LLC | $21.13 | 2022 | |
| Axonics, INC. | $16.45 | 2021 | |
| Glaxosmithkline, LLC. | $14.49 | 2024 | Bexsero |
| Coloplast Corp | $14.05 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Gronert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.